pharma · Locally advanced or metastatic urothelial cancer · Nectin-4 Expressing Advanced Malignancies. · BCYC
BICYCLE THERAPEUTICS
BICYCLE THERAPEUTICS clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Cambridge, GB HQ
2009 Founded
282 Employees
Public company Type
BCYC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, GB
- Founded
- 2009
- Employees
- 282
- Programs
- 8
- Drugs
- 15
- Patents
- 57
BICYCLE THERAPEUTICS projects
2 ClinicalTrials.gov programs sponsored by BICYCLE THERAPEUTICS.
BICYCLE THERAPEUTICS has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does BICYCLE THERAPEUTICS have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.